Erythroid Maturation Agent [EPC]

2614 reported adverse events

Drugs of this class: LUSPATERCEPT

These side effects are most commonly reported by patients taking drugs of the Erythroid Maturation Agent [EPC] class:

# Side effect Count
0 DEATH 244
1 OFF LABEL USE 193
2 HAEMOGLOBIN DECREASED 144
3 FATIGUE 137
4 DRUG INEFFECTIVE 114
5 WEIGHT DECREASED 92
6 PRODUCT STORAGE ERROR 85
7 DIZZINESS 84
8 MYELODYSPLASTIC SYNDROME 75
9 DYSPNOEA 73
See all common reactions for Erythroid Maturation Agent [EPC]

Drugs of the Erythroid Maturation Agent [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYELODYSPLASTIC SYNDROME WITH RINGED SIDEROBLASTS 5 0.5556
1 EXTRAMEDULLARY HAEMOPOIESIS 31 0.1938
2 ASCENDING FLACCID PARALYSIS 2 0.0741
3 ERYTHROID DYSPLASIA 2 0.0667
4 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 38 0.0579
5 VENTILATION PERFUSION MISMATCH 12 0.0427
6 TRAUMATIC SUBARACHNOID HAEMORRHAGE 2 0.0312
7 SIDEROBLASTIC ANAEMIA 2 0.0143
8 VESTIBULAR MIGRAINE 3 0.0124
9 BLOOD PRODUCT TRANSFUSION DEPENDENT 4 0.0095
See all enriched reactions for Erythroid Maturation Agent [EPC]